KV

Kenneth Valenzano

AT Amicus Therapeutics: 13 patents #10 of 55Top 20%
UM Universite De Montreal: 1 patents #189 of 428Top 45%
Overall (All Time): #366,257 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12419937 High concentration alpha-glucosidase compositions for the treatment of Pompe disease John Crowley, Richie Khanna, John Flanagan 2025-09-23
11278599 High concentration alpha-glucosidase compositions for the treatment of Pompe disease John Crowley, Richie Khanna, John Flanagan 2022-03-22
10512677 High concentration alpha-glucosidase compositions for the treatment of pompe disease John Crowley, Richie Khanna, John Flanagan 2019-12-24
10357548 α-galactosidase A and 1-deoxygalactonojirimycin co-formulation Richie Khanna, Susan Elizabeth Fowles 2019-07-23
10155027 Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry disease Richie Khanna, Susan Elizabeth Fowles 2018-12-18
10046033 High concentration alpha-glucosidase compositions for the treatment of Pompe disease John Crowley, Richie Khanna, John Flanagan 2018-08-14
9937165 Pharmacological chaperones for treating obesity Jian-Qiang Fan, Gary Lee, Michel Bouvier, Patricia René 2018-04-10
9931353 Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases Brandon Wustman, Robert Boyd 2018-04-03
9694056 α-galactosidase A and 1-deoxygalactonojirimycin co-formulation Richie Khanna, Susan Elizabeth Fowles 2017-07-04
9404100 High concentration alpha-glucosidase compositions for the treatment of Pompe disease John Crowley, Richie Khanna, John Flanagan 2016-08-02
9381194 Pharmacological chaperones for treating obesity Jian-Qiang Fan, Gary Lee, Michel Bouvier, Patricia René 2016-07-05
9303249 High concentration α-glucosidase compositions for the treatment of Pompe disease John Crowley, Richie Khanna, John Flanagan 2016-04-05
9044437 Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases Brandon Wustman, Robert Boyd 2015-06-02